Phase 2 Bladder Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must be 18 years old or older at the time of screening.
- You must have been diagnosed with advanced or spreading bladder/urinary tract cancer that has been confirmed by a tissue sample (biopsy).
- Your cancer must be measurable on scans using standard medical guidelines.
- You must be generally well enough to carry out daily activities with little or no limitation (confirm with trial site for exact fitness level required).
- Your blood, liver, and kidney test results must be within acceptable ranges.
- You must be willing to follow the study procedures and sign a consent form agreeing to take part.
- If you are able to become pregnant, you must agree to use effective birth control during the study and for a set period of time after your last dose.
Who may not be able to join:
- You may not be eligible if you have had another type of cancer in the past 3 years, or if there are still signs of a previous cancer in your body.
- You may not be eligible if you have active cancer that has spread to your brain or spinal cord.
- You may not be eligible if you have an autoimmune disease (where your immune system attacks your own body) that has needed treatment in the past 2 years.
- You may not be eligible if you have taken part in another clinical trial within the last 30 days or within a certain timeframe related to the previous trial medication (confirm with trial site).
- You may not be eligible if you are currently pregnant or breastfeeding.
- You may not be eligible if you are unable or unwilling to follow the study's requirements.
- You may not be eligible if you or a close family member works directly on this clinical trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Pfizer CT.gov Call Center, Pfizer
Phone: 1-800-718-1021
Australian sites
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
3 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Confirmed Objective Response Rate (ORR) by investigator; Number of Participants with Treatment Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs); Number of participants with dose limiting toxicity (DLT) in Part 1 of Cohort B
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.